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Open access under the ElOrganophosphates (OPs), which are widely used as pesticides, are acetylcholinesterase (AChE) and butyr-
ylcholinesterase (BChE) inhibitors. The inactivation of AChE results in the accumulation of acetylcholine
at cholinergic receptor sites, causing a cholinergic crisis that can lead to death. The classical treatment for
OP poisoning is administration of oximes, but these compounds are ineffective in some cases. Here we
determined whether the new compound isatin-3-N4-benzilthiosemicarbazone (IBTC), which in our pre-
vious study proved to be an antioxidant and antiatherogenic molecule, could protect and reactivate AChE
and BChE. Toxicity of IBTC after subcutaneous injection in mice was measured using assays for oxidized
dicloroﬂuoresceine (DCF), thiobarbituric acid reactive substances (TBARS), non-protein thiol (NPSH)
levels, and catalase (CAT), sodium potassium (Na+/K+) ATPase, delta-aminolevulinic acid dehydratase
(ALA-D), and glutathione peroxidases (GPx) enzyme activities. The cytotoxicity was evaluated and the
enzymatic activity of cholinesterase was measured in human blood samples. Molecular docking was used
to predict the mechanism of IBTC interactions with the AChE active site. We found that IBTC did not
increase the amount of DCF-RS or TBARS, did not reduce NPSH levels, and did not increase CAT, (Na+/
K+) ATPase, ALA-D, or GPx activities. IBTC protected and reactivated both AChE and BChE activities.
Molecular docking predicted that IBTC is positioned at the peripheral anionic site and in the acyl binding
pocket of AChE and can interact with methamidophos, releasing the enzyme’s active site. Our results sug-
gest that IBTC, besides being an antioxidant and a promising antiatherogenic agent, is a non-toxic mol-
ecule for methamidophos poisoning treatment.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Organophosphates (OPs), which inhibit cholinesterase, have
been widely used as pesticides and additives for lubricants and
have been developed as warfare nerve agents (WHO, 1993). The
toxic action of OPs is related to the binding of these compounds
to the active site of the acetylcholinesterase enzyme (AChE; EC
3.1.1.7), thus inhibiting hydrolysis of the acetylcholine neurotrans-
mitter (ACh) at central and peripheral synapses (Holmstedt, 1959;
Taylor et al., 1995). The inactivation of AChE results in an accumu-
lation of acetylcholine at cholinergic receptor sites and a choliner-
gic crisis that can lead to death, usually via respiratory failure due
to paralysis of the diaphragm and intercostals muscles, as well asm.br, felix@ufsm.br (F.A.A.
sevier OA license.cerebral respiratory center depression and excessive bronchial
secretion (Marrs, 1993).
The enzymes associated with antioxidant defense mechanisms
are altered under the inﬂuence of pesticides, leading to an imbal-
ance between generation of oxidant molecules and intracellular
antioxidant systems (Banerjee et al., 1999), which may induce oxi-
dative stress in rats (Gultekin et al., 2000; Gupta et al., 2001), mice
(da Silva et al., 2006, 2008), and humans (Banerjee et al., 1999).
Moreover, OPs cause lipid peroxidation in rat brains (Verma and
Srivastava, 2001) and human erythrocytes (Gultekin et al., 2000).
However, the exact mechanism by which OPs induce oxidative
damage is not fully understood (Abdollahi et al., 2004).
Methamidophos (MAP) is an OP and a potent AChE inhibitor
used to control insects that plague a variety of crops such as bras-
sica, cotton, tobacco, sugar beet, lettuce, potatoes, and tree fruits
(WHO, 1993). MAP is highly toxic to aquatic organisms (Tomlin,
1994) and mice (Zayed et al., 1984). It also has anticholinesterase
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(AchE) inhibition by OPs can generally be reversed by treatment
with oximes (Worek et al., 2004). However, there is a need for
more efﬁcient compounds with broader reactivation activity after
exposure to different OPs and that are less toxic to humans.
The crystal structure of AChE (Bourne et al., 1995; Ekström
et al., 2006; Kryger et al., 1998; Sussman et al., 1991) allows for de-
tailed structural studies on ligand access to the enzyme’s active
center gorge and the steric constraints within the active center
gorge that govern selectivity during reactivation (Ashani et al.,
1995; Grosfeld et al., 1996; Kovarik et al., 2004; Wong et al.,
2000). The orientation of the compound within the narrow con-
ﬁnes of the gorge when the active serine is phosphorylated is an
important determinant of the reactivation mechanism (Musilek
et al., 2011). There are several in silico studies that illustrate the
ability of this structural model to reliably predict molecular
interactions.
There is considerable interest in thiosemicarbazones due to
their wide pharmacological utility (Beraldo and Gambino, 2004)
and versatility as ligands. They have recently been investigated
as radical scavengers (Wada et al., 1994) and our previous study
(Barcelos et al., 2011) revealed that a thiosemicarbazone derivate,
isatin-3-N4-benzilthiosemicarbazone (IBTC), is also effective as an
antioxidant and antiatherogenic molecule. Although the use of thi-
osemicarbazone as an antiatherogenic molecule has been sug-
gested previously (Barcelos et al., 2011), in vitro and in vivo
toxicological screening is still needed.
Therefore, the aim of this study was to test the toxicological ef-
fects of IBTC, a thiosemicarbazone derivate, and to identify the
effective concentration of IBTC for protecting and reactivating cho-
linesterases after exposure to MAP. In addition, any possible inhib-
itory effects of IBTC on the thiol-containing enzymes from the
blood/liver and brain, namely delta-aminolevulinic acid dehydra-
tase (ALA-D) and Na+/K+-ATPase, respectively, were also evaluated.
Docking studies were carried out in silico to evaluate the minimal
energy IBTC conformations in the active site of human AChE when
the active site serine is phosphorylated by MAP.2. Materials and methods
2.1. Synthesis of isatin-3-N4-benzilthiosemicarbazone
The synthesis of isatin-3-N4-benzilthiosemicarbazone (IBTC)
was performed as described previously (Fonseca et al., 2010) and
the chemical structure of IBTC is depicted in Fig. 1.2.2. Chemical reagents
The reagents thiobarbituric acid (TBA), dicloroﬂouresceine diace-
tate (DCFH-DA), methyltetrazolium (MTT), ethylene glycol tetraace-
tic acid (EGTA), Ellman’s reagent (5,50-dithiobis-(2-nitrobenzoic
acid) or DTNB), N,N,N0,N0-tetramethylbenzidine and ouabaine were
supplied by Sigma–Aldrich Chemical Co. (St. Louis, MO); acetylthi-
ocholine iodide supplied byMerck. The other used reagents were ob-
tained from local suppliers.Fig. 1. Chemical structure of IBTC.2.3. Separation of human red blood cells
Human red blood cells (RBC) were separated from heparinized
blood that was drawn from a healthy donor. The blood was centri-
fuged at 2000 rpm for 10 min to separated the RBCs from plasma,
then the RBCs were washed three times with phosphate-buffered
saline (PBS) at pH 7.4.2.4. Isolation of lymphocytes from human blood
Lymphocytes were isolated from human blood collected from a
healthy donor with EDTA and separated on Ficoll–Histopaque den-
sity gradients as described previously (Böyum, 1968).2.5. Cell culture
Cell culture Murine J774 macrophage-like cells were obtained
from the American Type Culture Collection (ATCC, Rockville, MD,
USA). These cells were maintained with Dulbecco’s Modiﬁed Eagle
Medium (DMEM) supplemented with 2 mM glutamine, 10 mM
HEPES, 100 U/mL penicillin, 100 lg/mL streptomycin and 10% fetal
bovine serum (FBS) in a 5% CO2 humidiﬁed atmosphere at 37 C.2.6. Experimental animals
Untreated adult male swiss albino mice (25–30 g) were ob-
tained from our own breeding colony. The animals were main-
tained in an air conditioned room (20–25 C) under a 12 h light/
dark cycle, and with water and food ad libitum. All the experimen-
tal procedures performed were conducted according to the guide-
lines of the Committee of Ethics in Research of the Federal
University of Santa Maria, Brazil.2.7. Animal treatment
Adult male swiss albino mice received a single subcutaneous
injection of the IBTC dissolved in DMSO in different doses (1, 10,
50, 100, 250 or 500 mg/kg) (n = 4 animals/dose). Control animals
received DMSO at 5 mL/kg. To determine the potential lethality
of the IBTC, animals were observed for up to 24 h after compound
administration. LD50 was calculated using ‘‘GraphPad Software’’
(GraphPad Software, San Diego, CA). After this period, animals
were euthanized by cervical dislocation. The liver, kidney, heart
and brain were quickly removed, placed on ice, and homogenized
within 10 min, in 10 volumes of cold Tris 10 mM (pH 7.4). The
homogenates were centrifuged at 4000g at 4 C for 10 min to yield
a low-speed supernatant fraction (S1) for each tissue that was used
for ex vivo analysis.2.8. Whole blood and blood components
Mice were euthanized and the whole blood was collected (car-
diac puncture) in previously heparinized tubes and kept under
refrigeration. Whole blood samples were precipitated with TCA
40% (1:1) and centrifuged (4000g at 4 C for 10 min) in order to ob-
tain the supernatant fraction that was used for non protein thiol
measurement determination. Other heparinized blood samples
were used for Delta Aminolevulinate Dehydratase (d-ALA-D) activ-
ity measurement and other were centrifuged at 1000g at 4 C for
10 min in order to obtain cellular blood fractions which were used
for oxidized dicloroﬂuoresceine and Delta Aminolevulinate Dehy-
dratase (d-ALA-D) activity measurement (Puntel et al., 2011).
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DCF-RS levels were determined as an index of the peroxide pro-
duction by the cellular components (Myhre et al., 2003). Aliquots
cellular blood fraction (10 lL) or liver, kidney, heart and brain S1
(50 lL) were added to a medium containing Tris–HCl buffer
(0.01 mM; pH 7.4) and DCFH-DA (7 lM). After DCFH-DA addition,
the medium was incubated in the dark for 1 h until ﬂuorescence
measurement procedure (excitation at 488 nm and emission at
525 nm and both slit widths used were at 5 nm). DCF-RS levels
were determined using a standard curve of DCF and the results
were corrected by the protein content (Pérez-Severiano et al.,
2004).
2.10. Thiobarbituric acid reactive substances (TBARS) levels
Analyses were performed in liver, kidney, heart and brain S1
samples according to the method described previously (Pérez-
Severiano et al., 2004). Aliquots of 200 lL of liver, kidney, heart
and brain S1 were added to color reaction. TBARS levels were mea-
sured at 532 nm using a standard curve of MDA and corrected by
the protein content (Ohkawa et al., 1979).
2.11. Catalase (CAT)
The CAT enzyme activity was determined in liver, kidney and
heart S1 according to the method proposed by Aebi H (Aebi,
1984). Brieﬂy, S1 aliquot (50 lL) was added to a medium contain-
ing potassium phosphate buffer (50 mM; pH 7.4) and H2O2 (1 mM).
The kinetic analysis of CAT was started after H2O2 addition and the
color reaction was measured at 240 nm. One unit of the enzyme is
considered as the amount which decomposes 1 lmol H2O2/min at
pH 7.
2.12. Sodium potassium (Na+/K+) ATPase
The cerebral Na+/K+ATPase enzyme activity was determined in
brain S1 samples according to the method proposed by Muszbek
et al. (1977), with some modiﬁcations. Brieﬂy, the aliquots of skel-
etal muscle S1 (20 lL) were added to a reaction medium contain-
ing NaCl (115 mM), MgCl2 (2.5 mM), KCl (18 mM) and Tris–HCl
buffer (45 mM and pH 7.4), with or without the Na+/K+ ATPase en-
zyme inhibitor ouabaine (5 lM). The method for ATPase activity
measurement was based on the determination of the inorganic
phosphate (Pi) released to the reaction medium by the hydrolysis
of the ATP according to the method proposed by Atkinson A (Atkin-
son et al., 1973). The reaction was initiated with the addition of the
substrate ATP (1.5 mM) to the reaction medium and was ﬁnished
by the addition of the color reagent (1 mL) containing ammonium
molibdate (2%), Triton-X 100 (5%) and H2SO4 1.8 M (10%) after
15 min of incubation at 37 C. The formed molibdate–Pi complexes
were measured spectrophotometrically at 405 nm. Values were
calculated in relation to a standard curve constructed with Pi at
known concentrations and corrected by the protein content.
2.13. Delta Aminolevulinate Dehydratase (d-ALA-D) activity assay
The enzyme was assayed as described previously (Sassa, 1982)
by measuring the rate of product porphobilinogen (PBG) forma-
tion. After 10 min of pre-incubation with homogenized liver or to-
tal blood from treated mice at 37 C, in a medium containing
100 mM potassium phosphate buffer, pH 6.8, the enzymatic reac-
tion was initiated by adding the substrate aminolevulinic acid
(ALA) to a ﬁnal concentration of 2.5 mM. The incubation was car-
ried out for 1 h, at 37 C, and was stopped by adding 10% TCA con-
taining 10 mMHgCl2. The reaction product was determined using amodiﬁed Ehrlich’s reagent at 555 nm, with a molar absorption
coefﬁcient of 6.1  104 for the Ehrlich porphobilinogen salt. The
enzyme activity was expressed in percent of the control.2.14. Glutathione peroxidases (GPx) assay.
GPx was determined as described previously (Paglia and Valen-
tine, 1967). Tissue supernatants (200–400 lg protein) were added
to the assay mixture consisting of 1 mM sodium azide, 1 mM GSH,
50 mM potassium phosphate (pH 7.0), and 0.1 unit of glutathione
reductase. Reaction was started by the addition of hydrogen perox-
ide (H2O2) to give a ﬁnal concentration of 0.4 mM. Conversion of
NADPH to nicotinamide adenine dinucleotide phosphate (NADP+)
was monitored continuously at 340 nm for 2 min. GPx activity
was expressed as nmol of NADPH oxidized per minute per milli-
gram of protein, using an extinction coefﬁcient 6.22  106
M1 cm1 for NADPH.2.15. Non protein thiol measurement (NPSH)
To estimate GSH content we determined NPSH as follows:
500 lL of 10% TCA was added to 500 lL of either the S1 homoge-
nates of liver, or kidney, or heart or brain. After centrifugation
(4000g at 4 C for 10 min), the protein pellet was discarded and
free –SH were determined in the clear supernatant (which was
previously neutralized with 0.1 M NaOH) according to Ellman
(1959).2.16. Cytotoxicity assays
2.16.1. Percent of hemolysis in human red blood cells
The 5% suspension RBCs in PBS (pH 7.4) was incubated under air
atmosphere at 37 C for 240 min, into IBTC concentrations from 10
to 200 lM were added to the medium. The reaction mixture was
shaken gently while being incubated at 37 C. The extent of hemo-
lysis was determined spectrophotometrically as described previ-
ously (Kuang et al., 1994). Brieﬂy, aliquots of the reaction
mixture were taken out at appropriate time intervals, diluted with
NaCl (0.15 M), and centrifuged at 2000 rpm for 10 min to separate
the RBCs. The percentage hemolysis was determined by measuring
the absorbance of the supernatant at 540 nm and compared with
that of complete hemolysis by treating the same RBC suspension
with distilled water.2.16.2. MTT assay
Percent cytotoxicity of IBTC was assessed using the 3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT)
assay as described previously (Mosmann, 1983). Brieﬂy, Murine
J774 macrophage-like cells (1  104) were allowed to adhere for
24 h under high humid environment in 5% CO2 at 37 C in 96 well
culture plates. Also human lymphocytes were freshly isolated as
described previously (Böyum, 1968) and plated in 96-well ﬂat bot-
tom tissue culture plate at a concentration of 1  105 cells/well
containing 200 ll of RPMI-1640 supplemented with 10% FCS tissue
culture medium. Then, for the both type of cells, IBTC concentra-
tions from 10 to 200 lMwere added to the medium and incubated
for 24 h. After the respective exposure, MTT (5 mg/ml of stock in
PBS) was added (10 ll/well in 100 ll of cell suspension), and plates
were incubated for 4 h. At the end of incubation period, 200 ll of
DMSO was added to each well. The plates were kept on shaker
for 5 min at room temperature and then read at 550 nm using
FisherBiotech Microkinetics Reader BT 2000. Untreated sets were
also run under identical conditions and served as basal control.
Table 1
Effect of IBTC treatment on DCF-RS levels on liver, kidney, heart and brain
homogenates.
DCF-RS levels (Mean ± SEM)
Liver Kidney Heart Brain
Control 100.00 ± 0.95 100.00 ± 1.13 100.00 ± 2.26 100.00 ± 1.08
1 mg/kg 115.73 ± 5.63 109.41 ± 0.72 88.4 ± 5.02 95.26 ± 6.21
10 mg/kg 114.10 ± 4.98 104.91 ± 2.13 93.52 ± 6.15 92.04 ± 1.94
50 mg/kg 107.24 ± 3.69 102.86 ± 1.32 110.08 ± 1.25 103.39 ± 2.54
100 mg/kg 115.16 ± 5.68 101.41 ± 1.54 89.03 ± 4.51 80.10 ± 6.20
250 mg/kg 121.09 ± 7.64 103.71 ± 3.37 99.82 ± 4.26 81.74 ± 5.76
500 mg/kg 112.03 ± 4.97 100.14 ± 3.43 102.26 ± 5.49 91.20 ± 1.49
Data are expressed as percentage of the control. The values are expressed as
mean ± SEM of four independent experiments in duplicate. Data were analyzed by
analysis of variance (ANOVA), followed by Student–Newman–Keuls post hoc test.
Values of p < 0.05 were considered signiﬁcant.
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2.17.1. Preparation of erythrocyte ghosts and plasma
Hemoglobin-free erythrocyte ghosts were prepared as previ-
ously described (Worek et al., 2002) with minor modiﬁcations.
Brieﬂy, blood of non-fasted healthy voluntary donors was col-
lected. Heparinised human blood was centrifuged (3000g,
10 min) and the plasma removed and kept to test butyrylcholinest-
erase activity. Erythrocytes were washed three times with two vol-
umes of sodium/potassium phosphate buffer (0.1 M, pH 7.4). Then,
the packed erythrocytes were diluted in 20 volumes of hypotonic
sodium/potassium phosphate buffer (6.7 mM, pH 7.4) to facilitate
the hemolysis, followed by centrifugation at 30,000g (30 min,
4 C). The supernatant was removed and the pellet resuspended
in hypotonic phosphate buffer. After two additional washing cy-
cles, the pellet was resuspended in sodium/potassium phosphate
buffer (0.1 M, pH 7.4), passed through one more centrifugation at
30,000g (30 min, 4 C) and were kindly removed. Next, the AChE
activity was adjusted to the original activity by appropriate dilu-
tion with phosphate buffer (0.1 M, pH 7.4). Aliquots of the erythro-
cyte ghosts were stored at 20 C until use.
Hemoglobin content present in ghost membranes was mea-
sured at 540 nm as the cyano-met-Hb form, but no hemoglobin
was detected.
2.17.2. Measure of cholinesterases activity
Ghost erythrocyte acetylcholinesterase and human plasma
butyrylcholinesterase activities were estimated by Ellman method
(Ellman et al., 1961), using acetylthiocholine iodide as substrate.
The rate of hydrolysis of acetylthiocholine iodide is measured at
412 nm through the release of the thiol compound that, when re-
acted with DTNB, produces the color-forming compound TNB.
Whole blood AChE was measured by Ellman method (Ellman
et al., 1961) with modiﬁcations (Worek et al., 1999a,b). For butyr-
ylcholinesterase activity, the same protocol was used, but butyr-
ylthiocoline iodide was used as the substrate.
2.17.3. Reactivation/protection of OP-inhibited cholinesterase
Ghost erythrocyte acetylcholinesterase and human plasma
butyrylcholinesterase were exposed to IBTC in two different assay
conditions in order to identify a possible protective or a reactiva-
tion capacity of IBTC:
(a) Protection: the enzyme was exposed to methamidophos
(MAP) 25 lM and IBTC (10–100 lM) at the same time into
a total incubation period of 60 min.
(b) Reactivation: the enzyme was ﬁrstly exposed to MAP 25 lM
by 10 min (estimated time before aging). After this, the IBTC
(10–100 lM) tested was added into the medium and the
incubation followed by 50 min (to perform an equal total
incubation time period of 60 min). Enzyme activities were
referred to control activity.
The different protocols aim to test the prophylactic and thera-
peutic effect of IBTC on MAP-induced AChE inhibition.
2.18. Protein determination
The protein content was determined as described previously
(Lowry et al., 1951) using bovine serum albumin (BSA) as standard.
2.19. Molecular docking
Docking simulations of the oximes with Mus musculus AChE
were carried out using AutoDock Vina 1.1.1 (Trott and Olson,2010), followed by redocking with Autodock 4.0.1. The non-aged
MAP-inhibitedMus musculus AChE obtained from the RCSB Protein
Data Bank (http://www.rcsb.org/pdb/) was used as macromolecule
(PDB code 2jge). IBTC was constructed using the program Avogadro
0.9 and their geometry were optimized with the MMFF 94 force
ﬁeld. Both ligand and macromolecule are previously prepared
using AutoDock Tools (Morris et al., 2009) and Chimera 1.5 (Petter-
sen et al., 2004). All rotatable bonds within the ligands were al-
lowed to rotate freely, and the receptor was considered rigid. The
grid was centered on the active site of from AChE and the dimen-
sions of the grid box were consisted of 30 Å  22 Å  30 Å points,
with spacing of 1 Å. The exhaustiveness was set to 50. All other
parameters were used as defaults. For the ligand docked, the con-
formation from the lowest binding free energy with inferred inhib-
itory reactivity was accepted as the best afﬁnity model. The
redocking calculation were carried out using Autodock 4.0.1, fol-
lowing method of Musilek et al. (2011). Brieﬂy, a Lamarckian ge-
netic algorithm (Amber force ﬁeld) was used, and a population of
150 individuals and 2500,000 function evaluations were applied.
The structure optimization was performed for 27,000 generations.
Docking calculations were set to 100 runs. At the end of calcula-
tion, Autodock performed cluster analysis. The 3D afﬁnity grid
box was designed to include the full active and peripheral site of
AChE. The number of grid points in the x-, y- and z-axes was 60,
60 and 60 with grid points separated by 0.253 Å. The conforma-
tions and interactions were analyzed using the programs Accelrys
Discovery Studio Visualizer 2.5 and PyMOL (Seeliger and de Groot,
2010).
2.20. Statistical analysis
Data are expressed as means ± SEM. Statistical analysis was per-
formed using one-way analysis of variance (ANOVA), followed by
Student–Newman–Keuls test when appropriate. In addition, linear
regression was performed to identify a possible dose dependent ef-
fect. Values of p < 0.05 were considered signiﬁcant.
3. Results
3.1. Ex vivo toxicology screening
Table 1 shows that IBTC did not signiﬁcantly affect DCF-RS lev-
els in tissue homogenates. In addition, lipid peroxidation, indicated
by TBARS levels (Table 2), did not change signiﬁcantly in liver,
kidney, or brain homogenates after treatment with any concentra-
tion of IBTC. However, there was a signiﬁcant reduction in TBARS
level in heart homogenates after treatment with most of the con-
centrations of IBTC. NPSH levels did not change in liver, kidney,
Table 2
Effect of IBTC treatment on TBARS levels on liver, kidney, heart and brain homogenates.
TBARS levels (Mean ± SEM)
Liver Kidney Heart Brain
Control 100.00 ± 4.35 100.00 ± 1.18 100.00 ± 1.74 100.00 ± 4.86
1 mg/kg 99.75 ± 17.49 95.66 ± 7.52 67.96 ± 8.93* 111.17 ± 10.3
10 mg/kg 84.10 ± 6.54 75.98 ± 6.95 58.41 ± 9.10* 114.54 ± 5.90
50 mg/kg 106.45 ± 12.08 69.07 ± 11.57 69.55 ± 10.25* 80.48 ± 7.82
100 mg/kg 120.95 ± 11.09 96.60 ± 12.91 61.24 ± 2.67* 86.30 ± 7.83
250 mg/kg 115.83 ± 7.76 94.09 ± 10.21 65.99 ± 9.99* 76.64 ± 10.53
500 mg/kg 118.91 ± 1.27 89.91 ± 3.29 81.65 ± 8.06 92.44 ± 5.93
Data are expressed as percentage of the control. The values are expressed as mean ± SEM of four independent experiments in duplicate. Data were
analyzed by analysis of variance (ANOVA), followed by Student–Newman–Keuls post hoc test. Values of p < 0.05 were considered signiﬁcant.
* Indicates statistical difference from control group (p < 0.05).
Table 3
Effect of IBTC treatment on NPSH levels on liver, kidney, heart, brain homogenates.
NPSH levels (Mean ± SEM)
Liver Kidney Heart Brain
Control 100.00 ± 0.61 100.00 ± 4.44 100.00 ± 2.92 100.00 ± 1.55
1 mg/kg 91.09 ± 5.22 133.30 ± 15.22 90.44 ± 5.67 125.79 ± 1.01
10 mg/kg 91.90 ± 15.14 111.93 ± 12.46 86.15 ± 7.00 104.61 ± 1.45
50 mg/kg 95.78 ± 2.25 154.59 ± 14.39 100.35 ± 11.38 108.69 ± 7.67
100 mg/kg 83.00 ± 8.33 131.21 ± 6.53 97.49 ± 13.59 159.13 ± 14.13*
250 mg/kg 96.67 ± 13.73 133.16 ± 9.94 96.81 ± 10.75 186.15 ± 28.37*
500 mg/kg 98.75 ± 2.27 135.65 ± 16.61 113.22 ± 8.56 176.34 ± 12.24*
Data are expressed as percentage of the control. The values are expressed as mean ± SEM of four independent experiments in duplicate. Data were
analyzed by analysis of variance (ANOVA), followed by Student–Newman–Keuls post hoc test. Values of p < 0.05 were considered signiﬁcant.
* Indicates statistical difference from control group (p < 0.05).
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Fig. 2. Effect of IBTC treatment on Na+/K+ ATPase activity on brain homogenate.
Na+/K+ ATPase activity is expressed as nmol Pi/min/mg protein. The values are
expressed as mean ± SEM of four independent experiments in duplicate. Data were
analyzed by analysis of variance (ANOVA), followed by Student–Newman–Keuls
post hoc test. Values of p < 0.05 were considered signiﬁcant.
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enates after treatment with IBTC (Table 3). Catalase and GPx activ-
ities did not change signiﬁcantly (data not shown). In addition,
Na+/K+ ATPase activity in the brain (Fig. 2) and ALA-D activity in li-
ver and blood (Fig. 3A and B) did not change signiﬁcantly. In addi-
tion, LD50 was considered higher than 500 mg/kg.
3.2. Cell viability
3.2.1. Percent of hemolysis
The percent of hemolysis in RBCs in the presence of various con-
centrations (10–200 lM) of IBTC did not change signiﬁcantly
compared to controls (data not shown).3.2.2. MTT assay
Murine J774 macrophage-like cells and isolated human lym-
phocytes were used to test the cytotoxicity of IBTC. Fig. 4 shows
the MTT levels in these cell types. Concentrations of 50 lM of IBTC
and above signiﬁcantly reduced MTT levels compared to controls
in J774 macrophage-like cells (Fig. 4A). The MTT levels did not
change signiﬁcantly compared to controls in isolated human lym-
phocytes (Fig. 4B).3.3. Cholinesterase activity
MAP exposure at a concentration of 25 lM inhibited AChE and
BChE activity in all samples. None of the IBTC concentrations tested
had a signiﬁcant effect on AChE or BChE activity (data not shown).
No direct hydrolytic effect of IBTC on acetylthiocholine or butyryl-
thiocholine was observed (data not shown).
IBTC protected against MAP-inhibition of AChE and BChE in hu-
man erythrocyte ghosts (Fig. 5A and B). Treatment with MAP plus
IBTC (at 10, 25, 50, and 100 lM) resulted in signiﬁcantly increased
cholinesterase activity compared to MAP alone (Fig. 5A and B).
IBTC also signiﬁcantly (p < 0.05) reactivated the AChE and BChE en-
zyme activities at concentrations of 10, 25, 50, and 100 lM (Fig. 6A
and B) compared to MAP alone.3.4. Molecular docking results
Since different enantiomers of methamidophos can bind to
Ser203, Sp and Rp we performed docking studies with both Sp
(SGX) and Rp (SGR) enantiomers of MAP-inhibited AChE from
Mus musculus (PDB code: 2jge) (Fig. 7). In the Rp conformation of
methamidophos, IBTC was located in the active site between the
peripheral anionic site (PAS) (Tyr124) and the internal anionic site
(Tyr341). The binding energy was 9.2 kcal/mol for the Rp enan-
tiomer. The thiocarbonyl group was 7.707 angstroms from the
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icarbazone function was 2.873 Å from the carboxylic oxygen of res-
idue Asp74 and 3.305 Å from the oxygen of residue Tyr341. The
terminal thioamidic nitrogen hydrogen bonded with residue
Tyr124 of the peripheral anionic site. The other fragment of the
molecule was located close to the internal anionic site and stabi-
lized by hydrogen bonds with residues Thr83 (nitrogen of the in-
dole group) and Tyr337 (hydrogen bond with the amidic oxygen
and the iminic nitrogen present on the thiosemicarbazone func-
tion). Only one cation–Pi interaction occurred between IBTC and
the enzyme active site, which was between the aromatic ring from
the terminal thioamidic function and phosphate of the SER203.
In the Sp conformation of methamidophos, similar to the Rp
enantiomer of the serine modiﬁed by MAP, IBTC was stabilized in
the active site between the peripheral anionic site (PAS) (Tyr124)
and the internal anionic site (Tyr341). The binding energy was
8.95 kcal/mol. The thiocarbonyl group was 6.311 Å from the
phosphate of SGX203 and the hydrazinic nitrogen of the thiosem-
icarbazone function was 2.818 Å from the carboxylic oxygen of res-
idue Asp74 and 3.271 Å from the oxygen of residue Tyr341. In this
conformation (SGX), the sulfur group was closer to the phosphate
of the modiﬁed serine than in the SGR conformation. The aromatic
ring from the terminal thioamidic function was stabilized in a
hydrophobic region between the PAS (Tyr337 and Tyr341) and
the acyl binding pocket (Phe338). The amidic oxygen formed a
hydrogen bond with residue Tyr337 as well as with the iminic
nitrogen. There was also a hydrogen bond between residue Thr87and the iminic nitrogen. Pi interactions did not directly occur with
the molecule.4. Discussion
One purpose of our study was to investigate the potential toxic
properties of IBTC, a compound that has been investigated in many
biological models of oxidative stress. In our previous study (Barce-
los et al., 2011) we demonstrated that this compound has high
antiatherogenic potential. However, its toxicity to organisms as
well as its possible action on cholinesterases had not been yet elu-
cidated. In the present study we showed that subcutaneous injec-
tion of IBTC did not increase oxidative stress, had no impact on
enzymes usually affected by pesticide compounds (Banerjee
et al., 1999; Gultekin et al., 2000; Gupta et al., 2001), and did not
induce alterations in several antioxidant enzymes (Tables 1–3;
Figs. 2 and 3). In addition, our study clearly demonstrates that IBTC
can protect and reactivate AChE and BChE inhibited by MAP (Figs. 5
and 6).
We investigated IBTC in vivo in order to determine whether it
had any toxic effects in mice. We found that IBTC has low toxicity
when administered by subcutaneous (s.c.) injection, with an LD50
of higher than 500 mg/kg, and had no effect on body weight (data
not shown). No cytotoxicity was detected in isolated human lym-
phocytes and only concentrations of 50 lM and higher lowered
MTT levels in murine J774 macrophage-like cells. Moreover, the
presence of IBTC did not change the percent of hemolysis in RBCs
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Fig. 5. Protective effect of IBTC on AChE activity from ghost erythrocytes (A) and
BChE from plasma (B) on methamidophos (MAP) inhibition. IBTC was added to the
reaction medium at the same time of methamidophos. The data are expressed as
percentage from control group (100%) of ﬁve independent experiments in duplicate.
Data were analyzed by analysis of variance (ANOVA), followed by Student–
Newman–Keuls post hoc test. Values of p < 0.05 were considered signiﬁcant. 
indicates statistical difference from control group (p < 0.05) # indicates statistical
difference from methamidophos 25 lM group (p < 0.05).
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Fig. 6. Reactivation effect of IBTC on AChE activity from ghost erythrocytes (A) and
BChE from plasma (B) on methamidophos (MAP) inhibition. IBTC was added 10 min
after methamidophos in the reaction medium. The data are expressed as percentage
from control group (100%) of ﬁve independent experiments in duplicate. Data were
analyzed by analysis of variance (ANOVA), followed by Student–Newman–Keuls
post hoc test. Values of p < 0.05 were considered signiﬁcant.  indicates statistical
difference from control group (p < 0.05) # indicates statistical difference from
methamidophos 25 lM group (p < 0.05).
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et al. (2009) who found that thiosemicarbazone-derived com-
pounds have low toxicity.
Although we did not speciﬁcally measure RS formation, it is
well known that excessive RS could not only induce DCF-RS forma-
tion but also contribute to the initiation of a complex cascade of
reactions that culminates with lipid peroxidation (increase in
TBARS levels). We demonstrated that IBTC did not change DFC-
RS levels and did not increase lipid peroxidation, indicating that
IBTC does not produce excessive RS itself or disrupt the cellular
environment such that RS production increases. In addition, we
found that there was no depletion in NPSH levels and no changes
in catalase and GPx activities, indicating that there was no deple-
tion or alteration of these antioxidant systems.
d-ALA-D is an enzyme that catalyzes the condensation of two d-
aminolevulinic acid (ALA) molecules into porphobilinogen. Conse-
quently, d-ALA-D inhibition may impair heme biosynthesis (Jaffe,1995) and can result in the accumulation of d-ALA, which may af-
fect aerobic metabolism and have some prooxidant activity (Bec-
hara et al., 1993). Moreover, d-ALA-D activity is a good marker of
oxidative stress (Maciel et al., 2000) and can be inhibited by thiol
oxidized radicals (Farina et al., 2001; Folmer et al., 2003). Here
we demonstrated that there were no signiﬁcant effects on d-ALA-
D activity, indicating that IBTC does not affect the essential –SH
groups on the active site of the enzyme or increase oxidative stress.
Na+/K+-ATPase, a sulfhydryl-containing enzyme, is embedded in
the cell membrane and is responsible for the active transport of so-
dium and potassium ions in the nervous system. Since Na+/K+-ATP-
ase is crucial for maintaining ionic gradients in neurons (Xiong and
Stringer, 2000), a reduction in the activity of this enzyme may af-
fect neural activity and memory storage (Balk et al., 2010). Our
study demonstrated that the Na+/K+-ATPase activity was not mod-
iﬁed by IBTC at any of the concentrations tested, indicating that
IBTC has no toxic properties to neurons. Previous reports have
Fig. 7. Representative molecular models of IBTC binding the active site ofMus musculus AChE in the two different enantiomers for the methamidophos-modiﬁed Ser203: SGX
(left panel) and SGR (right panel). Ligand is shown in ball-and-stick drawing, the carbons of the ligand is shown in yellow. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
R.P. Barcelos et al. / Toxicology in Vitro 26 (2012) 1030–1039 1037demonstrated the importance of thiol groups for Na+/K+-ATPase
catalysis and –SH groups of this enzyme are highly susceptible to
oxidizing agents (Bavaresco et al., 2003; de Assis et al., 2003).
The unchanged NPSH levels found here are in agreement with
the unchanged activities of ALA-D and Na+/K+-ATPase.
We also demonstrate that IBTC did not alter the activity of AChE
and BChE, enzymes related to dysfunctions in the cholinergic neu-
rotransmission (Mukherjee et al., 2007) and to systemic inﬂamma-
tory conditions, such as diabetes mellitus, hypertension, insulin
resistance, and hyperlipidemia (Das, 2007).
AChE and BChE are strongly related to the intoxications caused
by pesticides and the implications of pesticides residues on human
health have yet to be comprehensively documented. Pesticides
may induce oxidative stress, leading to generation of free radicals
and alterations in antioxidants, oxygen free radicals, scavenging
enzyme systems, and lipid peroxidation. This way, after verifying
that IBTC does not alter antioxidant systems and has no toxic ef-
fects, we tested the capacity of IBTC to protect and reactivate the
activity of AChE and BChE after inhibition with MAP. In human
erythrocyte ghost and in human plasma BChE, IBTC was able to
protect and reactivate both enzymes from MAP inhibition at all
concentrations tested (Figs. 5 and 6). The protective activity for
AChE and BChE against MAP inhibition works via competitive
inhibition.Scheme 1. Possible mechanism of IBTC reactivMolecular docking results indicate that IBTC can enter the ac-
tive site of AChE by binding to the peripheral anionic site
(Trp134 and Tyr124) and internal anionic site (Thr83 and
Tyr337), thus preventing MAP from accessing the catalytic residue
Ser203 and protecting AChE and BChE from inhibition, and proving
that IBTC cannot itself inhibit AChE or BChE, since in vitro tests
demonstrate that the presence of IBTC on these sites do not affect
AChE and BChE activities.
Our most interesting result is that IBTC can reactivate AChE and
BChE after inhibition by MAP. As far as we know, there are few
compounds that are not oximes that can reactivate AChE and BChE
inhibited by OPs and there is no literature concerning the use of
thiosemicarbazones against OP intoxication. In that way, our study
demonstrates for the ﬁrst time that a thiosemicarbazone derivate
can protect and reactivate AChE and BChE from OP inhibition.
The use of many different oximes, the classical therapy for OPs poi-
soning, is controversial since metabolic degradation of oximes can
have deleterious effects, such as formation of toxic products such
as hydrogen cyanide, and numerous side effects, including nausea,
vomiting, dizziness, loss of consciousness, visual alterations,
confusion, headache, tachycardia, neuromuscular blockage, and
muscular weakness (Bardin et al., 1994; Carlton et al., 1998;
Hardman et al., 1996). New and more effective drugs with fewer
toxicological effects are necessary for cholinesterases reactivation.ation on methamidophos-inhibited AChE.
1038 R.P. Barcelos et al. / Toxicology in Vitro 26 (2012) 1030–1039In addition, oximes are weaker reactivators of BChE (Worek
et al., 1999a,b), and IBTC can reactivate both AChE and BChE activ-
ities. The reactivation of BChE is very important, since BChE is a co-
regulator of acetylcholine in brain (Giacobini, 2000) and replaces
AChE in the maintenance of the structure and physiological integ-
rity of the cholinergic system (Mesulam et al., 2002). Darvesh et al.
(2004) also showed that BChE is highly active in the synaptic cleft
in intrinsic cardiac neurons, helping to reduce high acetylcholine
levels (Darvesh et al., 2004). IBTC seems to reactivate cholinester-
ases via its position at the peripheral anionic site and the acyl bind-
ing pocket, which is in agreement with previous results obtained
for mono-oxime bisquaternary acetylcholinesterase reactivators
(Musilek et al., 2011).
As illustrated in Scheme 1, we observed that the imino hydrogen
(A) from IBTC can react with a carboxylate group (RCOO) of the
Asp74 residue (the distance of the imino hydrogen of the IBTC and
the RCOO group of the enzyme is about 2.8 Å), which could lead
to IBTC deprotonation and formation of an anionic intermediate
(B). Then, a nucleophilic attack by the thiolate on the electrophilic
center of methamidophos (B) can occur, which is the site of inhibi-
tion of the enzyme AChE (OR0). This intermediate has the phosphate
group (P) penta coordinated (C), which causes methamidophos to
leave the active site of the enzyme (OR0), reactivating the enzyme
and releasing the phosphate group, which returns to the tetrahedral
geometry bound only to IBTC (D). Based in thismechanism, the SGX,
not the SGR, conformation of the MAP-inhibited AChE seems to be
the more likely conformation to be reactivated since the sulfur
group is positioned closer to the electrophilic attack site (OPmoiety
in the modiﬁed Ser203). This is in agreement with previous work
that showed that Sp enantiomers (SGX conformation) of methyl-
phosphonate esters aremore reactive in forming the conjugatewith
the enzyme and the rates of reactivation by oximes also indicate a
preference of Sp over Rp (Wong et al., 2000).
5. Conclusion
The thiosemicarbazone derived compound, IBTC, besides acting
like an antioxidant and antiatherogenic (Barcelos et al., 2011), has
low toxicity and does not alter the antioxidant system. We have
demonstrated for the ﬁrst time that a thiosemicarbazone derivate
can protect AChE and BChE from MAP intoxication by preventing
MAP binding at the active site of the enzymes and can also reacti-
vate AChE and BChE activities by interacting with MAP and releas-
ing the active site. Future studies are needed to test IBTC against
intoxication by other OPs and also evaluate its efﬁcacy after
long-term exposure to MAP. However, our work indicates that IBTC
may be a useful therapeutic compound for MAP intoxication.
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